AssetMark Inc
ABUS icon

AssetMark Inc’s Arbutus Biopharma ABUS Stock Holding History

AssetMark Inc’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$81 Buy
+17
New +$82 ﹤0.01% 3697

Other funds holding ABUS

Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Carrera Capital Advisors
Carrera Capital Advisors Troy, Michigan $705M AUM 12.86% 1-Year Est. Return
Ledgewood Wealth Advisors
Ledgewood Wealth Advisors Exeter, New Hampshire $181M AUM 9.93% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
CenterBook Partners
CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return
Financiere des Professionnels
Financiere des Professionnels Montreal, Quebec, Canada $1.75B AUM 28.24% 1-Year Est. Return
KAM
Kazazian Asset Management Fort Lauderdale, Florida $115M AUM 9.41% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

AssetMark Inc's ABUS Position: Q3 2026 in Review

AssetMark Inc opened a new position in Arbutus Biopharma (ABUS) in Q3 2026: 17 shares worth $81. The stake represents ﹤0.01% of the portfolio and ranks #3697 among its holdings.

48 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.

  • AssetMark Inc held 17 shares of Arbutus Biopharma worth $81 as of Q3 2026.
  • Arbutus Biopharma was a new AssetMark Inc position in Q3 2026.
  • Arbutus Biopharma made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #3697 holding.
  • 48 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.